Newsletter | May 8, 2026

05.08.26 -- At INTERPHEX 2026 A Smarter Outsourcing Playbook Comes Into Focus

SPONSOR

Join Outsourced Pharm Live’s Jeff Buguliskis and panelists on May 11 at 11 AM ET for ADC Outsourcing: Plan Smart Now or Suffer LaterRegistration for this virtual event is free thanks to sponsor Lonza.

INDUSTRY INSIGHTS

Introducing Devices Earlier To Streamline The DDC Journey

Uncover how early device strategy and integrated planning can streamline development, reduce risk, and accelerate your path to commercial success.

The Top Tech Transfer Risks At Multi-Site CDMOs

Many tech transfer risks are avoidable with a single campus CDMO. With all manufacturing facilities on one site, drug sponsors can overcome obstacles and maintain speed en route to market.

Emerging Trends In Pharma Packaging

Pharmaceutical packaging must evolve alongside drug development to ensure stability, safety, and regulatory adherence, utilizing designs to improve therapeutic outcomes and patient accessibility.

FEATURED EDITORIAL

At INTERPHEX 2026 A Smarter Outsourcing Playbook Comes Into Focus

From AI explainability to geopolitical sourcing strategy, the Contract and Outsourcing Exchange Stage at Interphex 2026 delivered a clear message for drug sponsors: the days of passive, transactional CDMO relationships are over.

Selecting The Right eQMS To Maximize Quality Maturity

Let's take a closer look at the current electronic quality management system (eQMS) landscape in pharma/biotech and what a future-ready eQMS must enable to support continuous improvement.

INDUSTRY INSIGHTS CONTINUED

Risk Isn't Inevitable: How The Right CDMO Protects Your Programme

Risk in outsourced drug development is often created, not inherent. Learn how CDMO structure, continuity, and communication directly affect programme risk, timelines, and outcomes.

Corticosteroids And Hormonal Therapies — History, Use, And Future Outlook

Explore how evolving science, expanding global demand, and next-generation innovations are reshaping the future of corticosteroid and hormonal therapies — and what this transformation means for the future.

Early Solid Form Screening To Guide Drug Development

Conducting solid form screening early can help your team select and isolate the ideal lead polymorph to ensure manufacturability and stability while avoiding costs and hiccups down the road.

SOLUTIONS

Build Your Solution: Not Every Molecule Follows A Manual

Your Boutique CDMO Partner Of Choice

Control Software For Production Tablet Presses

The Shift Toward Self-Administration And Integrated Supply Chains

OUTSOURCED PHARMA CAPABILITIES UPDATE

Find Your New CDMO At Outsourced Pharma Capabilities Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: